These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 31418063)
21. Predominant bacteria and patterns of antibiotic susceptibility in urinary tract infection in children with spina bifida. Ortiz TK; Velazquez N; Ding L; Routh JC; Wiener JS; Seed PC; Ross SS J Pediatr Urol; 2018 Oct; 14(5):444.e1-444.e8. PubMed ID: 29709445 [TBL] [Abstract][Full Text] [Related]
22. Predicting Antibiotic Resistance in Urinary Tract Infection Patients with Prior Urine Cultures. Dickstein Y; Geffen Y; Andreassen S; Leibovici L; Paul M Antimicrob Agents Chemother; 2016 Aug; 60(8):4717-21. PubMed ID: 27216064 [TBL] [Abstract][Full Text] [Related]
23. Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections. Concia E; Bragantini D; Mazzaferri F J Chemother; 2017 Dec; 29(sup1):19-28. PubMed ID: 29271735 [TBL] [Abstract][Full Text] [Related]
24. Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study. Dayan N; Dabbah H; Weissman I; Aga I; Even L; Glikman D J Pediatr; 2013 Nov; 163(5):1417-21. PubMed ID: 23919903 [TBL] [Abstract][Full Text] [Related]
26. Urinary Tract Infection in Children: Management in the Era of Antibiotic Resistance-A Pediatric Urologist's View. Kutasy B; Coyle D; Fossum M Eur Urol Focus; 2017 Apr; 3(2-3):207-211. PubMed ID: 28965960 [TBL] [Abstract][Full Text] [Related]
27. Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009. Zilberberg MD; Shorr AF Infect Control Hosp Epidemiol; 2013 Sep; 34(9):940-6. PubMed ID: 23917908 [TBL] [Abstract][Full Text] [Related]
29. Management of urinary tract infections from multidrug-resistant organisms. Gupta K; Bhadelia N Infect Dis Clin North Am; 2014 Mar; 28(1):49-59. PubMed ID: 24484574 [TBL] [Abstract][Full Text] [Related]
30. Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: A systematic review and meta-analysis. Flokas ME; Detsis M; Alevizakos M; Mylonakis E J Infect; 2016 Dec; 73(6):547-557. PubMed ID: 27475789 [TBL] [Abstract][Full Text] [Related]
31. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common. Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462 [TBL] [Abstract][Full Text] [Related]
32. Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children. Dalgic N; Sancar M; Bayraktar B; Dincer E; Pelit S Scand J Infect Dis; 2011 May; 43(5):339-43. PubMed ID: 21271945 [TBL] [Abstract][Full Text] [Related]
34. Chronic urinary tract infections in patients with spinal cord lesions - biofilm infection with need for long-term antibiotic treatment. Tofte N; Nielsen AC; Trøstrup H; Andersen CB; Von Linstow M; Hansen B; Biering-Sørensen F; Høiby N; Moser C APMIS; 2017 Apr; 125(4):385-391. PubMed ID: 28407430 [TBL] [Abstract][Full Text] [Related]
35. Risk factors for community acquired urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing Zhu FH; Rodado MP; Asmar BI; Salimnia H; Thomas R; Abdel-Haq N Infect Dis (Lond); 2019; 51(11-12):802-809. PubMed ID: 31429616 [No Abstract] [Full Text] [Related]
36. Clinical Management of an Increasing Threat: Outpatient Urinary Tract Infections Due to Multidrug-Resistant Uropathogens. Walker E; Lyman A; Gupta K; Mahoney MV; Snyder GM; Hirsch EB Clin Infect Dis; 2016 Oct; 63(7):960-5. PubMed ID: 27313263 [TBL] [Abstract][Full Text] [Related]
37. Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients. Fatima S; Muhammad IN; Usman S; Jamil S; Khan MN; Khan SI Indian J Pharmacol; 2018; 50(2):69-74. PubMed ID: 30100654 [TBL] [Abstract][Full Text] [Related]
38. Resistance pattern of breakthrough urinary tract infections in children on antibiotic prophylaxis. Nateghian AR; Robinson JL; Mohandessi S; Hooman N J Infect Public Health; 2009; 2(3):147-52. PubMed ID: 20701875 [TBL] [Abstract][Full Text] [Related]
39. The frequency of Klebsiella pneumonia encoding genes for CTX-M, TEM-1 and SHV-1 extended-spectrum beta lactamases enzymes isolated from urinary tract infection. Dehshiri M; Khoramrooz SS; Zoladl M; Khosravani SA; Parhizgari N; Motazedian MH; Jahedi S; Sharifi A Ann Clin Microbiol Antimicrob; 2018 Feb; 17(1):4. PubMed ID: 29433582 [TBL] [Abstract][Full Text] [Related]
40. Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela. Guzmán M; Salazar E; Cordero V; Castro A; Villanueva A; Rodulfo H; De Donato M Biomedica; 2019 May; 39(s1):96-107. PubMed ID: 31529852 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]